Federal
Register Notices > Importers
>
Applied Science Labs
FR Doc E7-12950 [Federal Register: July 3, 2007 (Volume 72, Number 127)]
[Notices] [Page 36480-36481] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03jy07-82]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall, prior to issuing
a registration under this Section to a bulk manufacturer of a controlled
substance in schedule I or II and prior to issuing a registration under 21
U.S.C. 952(a)(2) authorizing the importation of such a substance, provide
manufacturers holding registrations for the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on
March 29, 2007, Applied Science Labs, Division of Alltech Associates Inc.,
2701 Carolean Industrial Drive, State College, Pennsylvania 16801, made
application by renewal to the Drug Enforcement Administration (DEA) to be
registered as an importer of the basic classes of controlled substances listed
in schedule I and II:
Drug
|
Schedule
|
Heroin (9200)
|
I
|
Cocaine (9041)
|
II
|
Codeine (9050)
|
II
|
Meperidine (9230)
|
II
|
Methadone (9250)
|
II
|
Morphine (9300)
|
II
|
The company plans to import these controlled substances for the manufacture
of reference standards.
Any manufacturer who is presently, or is applying to be, registered with
DEA to manufacture such basic classes of controlled substances may file
comments or objections to the issuance of the proposed registration and may,
at the same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by
21 CFR
1316.47.
Any such written comments or objections being sent via regular mail should
be addressed, in quintuplicate, to the Drug Enforcement Administration, Office
of Diversion Control, Federal Register Representative (ODL), Washington, DC
20537, or any being sent via express mail should be sent to Drug Enforcement
Administration, Office of Diversion Control, Federal Register Representative (ODL),
2401 Jefferson Davis Highway, Alexandria, Virginia 22301; and must be filed no
later than August 2, 2007.
This procedure is to be conducted simultaneously with, and independent of,
the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the Federal Register on September 23, 1975,
(40 FR 43745-46), all applicants for registration to import a basic class of
any controlled substances in schedule I or II are and will continue to be
required to demonstrate to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21 U.S.C
958(a), 21 U.S.C
823(a), and 21 CFR
1301.34(b), (c), (d), (e) and (f) are satisfied.
[[Page 36481]]
Dated: June 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E7-12950 Filed 7-2-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|